"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A study to gather information about radiotherapy (REQUITE)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study was done to find out more about patients who have radiotherapy for breast cancer, lung cancer or prostate cancer.
More about this trial
Radiotherapy is a common treatment for many types of cancer. It often works well but can cause side effects. As with most treatments, different people react differently to radiotherapy. Some have more side effects than others.
In the years before this study was done, researchers had been working on ways to predict who was more likely to have side effects. This included looking at the levels of specific biological markers (biomarkers), for example. But it is difficult and takes time.
In this study, researchers collected lots of information about thousands of people having radiotherapy. They hope that having a lot of information in one place will help researchers find ways of predicting who is more likely to have side effects.
The aim of the study was to create a large database of information about people who have had radiotherapy.
Summary of results
- people’s cancer diagnosis
- any treatment they had
- details of side effects they had
- how they were feeling
- how they rated their
quality of life
How to join a clinical trial
Professor Catharine West
European Commission’s FP7 health programme – GA601826 (funder)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Manchester